The Effectiveness of "MaRiTensi" in Increasing Self-Care and Blood Pressure Control: Randomized Controlled Trial

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

99 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-11

Study Completion Date

2024-04-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to know the effectiveness of "MaRiTensi" in improving knowledge, motivation, efficacy, self-care and blood pressure control for hypertension patients.

This study hypothesizes that MaRiTensi effectively increases the knowledge, motivation, self-efficacy and self-care of hypertensive patients and reduces blood pressure in the intervention group compared to the control group.

Respondent recruitment is as follows:

1. The respondent candidate will be identified based on data on record medical
2. Appropriate respondent candidates' criteria inclusion and exclusion contacted for given informed consent
3. Prospective respondents who are willing to participate and fulfill the criteria for pressure blood moment measurement will request signed consent
4. Respondents fill in the basic data and recapitulate by the assistant researcher
5. Done randomization for allocation of group interventions and group control
6. Respondents given envelope closed (using sequentially numbered, opaque sealed envelopes (SNOSE) method )
7. Respondents' group intervention was given maintenance by Hospital or health center standard-added intervention using MaRiTensi by conditions; meanwhile, group control was provided care by Hospital or health center standards.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Helping Relationship from Significant Others in Patients with Hypertension

NCT06854926

Hypertension Significant Others

NOT_YET_RECRUITING NA

Tension Tamer Randomized Control Trial

NCT03168789

Pre-hypertension

COMPLETED NA

Implementation Strategies for Self-Measured Blood Pressure Monitoring in Racially and Ethnically Diverse Populations

NCT06871462

Blood Pressure Monitoring, Home Hypertension

RECRUITING NA

Efficacy of Education Via Phone-based Text Messaging (SMS) on Patients With Uncontrolled Hypertension

NCT05711004

Hypertension

UNKNOWN NA

Postexercise Hypotension and Exercise Adherence

NCT03780309

Hypertension

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will be separated into two groups.

1. Respondents who have given consent will be given two questionnaires
2. Intervention group respondents will be given intervention for 12 weeks
3. Control group respondents will receive services according to the hospital or health center standards. Respondents will be asked to complete a questionnaire for the first evaluation during the first week of week six and to fill out a questionnaire for the final assessment in week 12.

Interventions in the form of utilizing "MaRiTensi" by the intervention group are given with the following conditions:

1. Intervention group and control group respondents filled out the Indonesian Version of the hypertension knowledge-level scale (HK-LS) questionnaire and the Indonesian Version of the Hypertension Self-care Profile (HBP-SCP)
2. Respondents were given a password to enter their data and log in to the "MaRiTensi" application.
3. Respondents will be given a simple and easy-to-understand tutorial on how to use "MaRiTensi."
4. Respondents measure blood pressure at least twice a week according to standards and record the results in the application
5. Respondents utilized every feature in MaRiTensi according to the needs of each respondent, including the question-and-answer feature
6. Respondents will be evaluated by telephone every two weeks by a research assistant to determine whether the respondent is following the intervention according to the procedure. Respondents who did not comply with the system were classified as lost follow-up
7. After using the "MaRiTensi" application, a post-test will be carried out at week six and week 12 using the Indonesian Version of the hypertension knowledge-level scale (HK-LS) and the Indonesian Version of the Hypertension Self-care Profile (HBP-SCP) questionnaire.

Data analysis in the third phase of the research was carried out by:

1. Editing Data originating from filling out the Indonesian Version of the hypertension knowledge scale (HK-LS) questionnaire and the Indonesian Version of the Hypertension Self-care Profile (HBP-SCP), as well as recording blood pressure in the application, will be examined for completeness, if there is incomplete data then will be asked back to the respondent to complete it.
2. Coding Coding will be provided for each questionnaire filled by respondents, especially for quantitative data according to the data scale. Coding is given according to the provisions in filling out the questionnaire (attached)
3. Tabulating Tabulating is done to convey respondents' demographic data in the third research and data on blood pressure, knowledge, motivation, self-efficacy, and self-care of hypertensive patients, as well as the results of the effectiveness analysis of "MaRiTensi" on these variables.

The data will be analyzed statistically using the paired t-test to analyze the first and second pre-test and post-test results. Comparison between the intervention and control groups will be analyzed by independent t-test. The first and second post-test outcome data will be subjected to an ANOVA test. All databases will be stored by researchers and validated by assessors, managed in a folder with a password so that not all teams can open it. Data analysis was carried out by the analyst, who performed it in a hidden manner, and the researcher will accept the data processing results for analysis to continue.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The intervention was given in the third phase of the research, namely "MaRiTensi," which was developed in the first and second stages of the research.

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Caregivers Outcome Assessors

In the research, the third stage will do double-blinding for the care provider and outcome assessor, who will evaluate blood pressure and questionnaires. Allocation concealment for dividing into groups, intervention and control will use the SNOSE (sequentially numbered, opaque sealed envelopes ) method. The envelope closed will be sorted by order randomization, given paper carbon with appearance. The same is true for envelopes with the inscription intervention or control.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MariTensi app and usual care

Patients use the MaRitensi application to manage their hypertension by utilizing various menus in the application and continue receiving treatment as usual for 12 weeks.

Group Type EXPERIMENTAL

MaRiTensi App

Intervention Type BEHAVIORAL

MaRiTensi is a mobile health-based hypertension self-management application used on Android smartphones.

MariTensi provides facilities for recording blood pressure, BMI, activity, examination results, education about hypertension, consultations, reminders and community chat.

Usual care

The patient was not given the MaRitensi application and only received treatment as usual.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MaRiTensi App

MaRiTensi is a mobile health-based hypertension self-management application used on Android smartphones.

MariTensi provides facilities for recording blood pressure, BMI, activity, examination results, education about hypertension, consultations, reminders and community chat.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

A patient registered in the medical record of RSPR, the doctor diagnosed with hypertension based on ICD 10: I10; Age 18 to \<60 years; owning and being able to use a smartphone; living in Yogyakarta during the study period; blood pressure ≥ 140/90 mmHg measured at the time of visit.

Exclusion Criteria

According to the doctor's diagnosis based on ICD 10:

1. Renal failure (ICD: N17-N19)
2. Diabetes Mellitus (ICD: E10-E14.9)
3. Stroke (ICD: I60-I69.8)
4. Acute Miocard Infarction (AMI) (ICD: I21-I21.9)
5. Heart Failure (ICD: I50-I50.9)
6. Cancer (ICD: C00-C97)
7. Dementia (ICD: F00-F04)
8. Mental disorders (ICD: F05-F99.9)
9. Thyroid Disease (ICD: E00-E07.9)
10. Human Immunodeficiency Virus (HIV) or Acquired Immunodeficiency Syndrome (AIDS) (ICD: B20)
11. Movement limitations: Hernia Nucleus Pulposus (HNP) (ICD: M50-M51.9); Piriformis Syndrome (ICD: G57-G57.9); Low Back Pain (LBP) (ICD: M54-M54.9); Frozen Shoulder (ICD: M75-75.9)

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No